These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 20663194)

  • 1. ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67.
    Tuominen VJ; Ruotoistenmäki S; Viitanen A; Jumppanen M; Isola J
    Breast Cancer Res; 2010; 12(4):R56. PubMed ID: 20663194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of the free web-based image analysis application ImmunoRatio for assessment of Ki-67 labelling index in breast cancer.
    Yeo MK; Kim HE; Kim SH; Chae BJ; Song BJ; Lee A
    J Clin Pathol; 2017 Aug; 70(8):715-719. PubMed ID: 28298390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technical note on the validation of a semi-automated image analysis software application for estrogen and progesterone receptor detection in breast cancer.
    Krecsák L; Micsik T; Kiszler G; Krenács T; Szabó D; Jónás V; Császár G; Czuni L; Gurzó P; Ficsor L; Molnár B
    Diagn Pathol; 2011 Jan; 6():6. PubMed ID: 21244664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of methods for accurate recognition of cells through nuclei staining of Ki-67 in neuroblastoma and estrogen/progesterone status staining in breast cancer.
    Markiewicz T; Wisniewski P; Osowski S; Patera J; Kozlowski W; Koktysz R
    Anal Quant Cytol Histol; 2009 Feb; 31(1):49-62. PubMed ID: 19320193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer.
    Rexhepaj E; Brennan DJ; Holloway P; Kay EW; McCann AH; Landberg G; Duffy MJ; Jirstrom K; Gallagher WM
    Breast Cancer Res; 2008; 10(5):R89. PubMed ID: 18947395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optimized image analysis algorithm for detecting nuclear signals in digital whole slides for histopathology.
    Paulik R; Micsik T; Kiszler G; Kaszál P; Székely J; Paulik N; Várhalmi E; Prémusz V; Krenács T; Molnár B
    Cytometry A; 2017 Jun; 91(6):595-608. PubMed ID: 28472544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer.
    Sharangpani GM; Joshi AS; Porter K; Deshpande AS; Keyhani S; Naik GA; Gholap AS; Barsky SH
    J Microsc; 2007 Jun; 226(Pt 3):244-55. PubMed ID: 17535263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AutoIHC-scoring: a machine learning framework for automated Allred scoring of molecular expression in ER- and PR-stained breast cancer tissue.
    Tewary S; Arun I; Ahmed R; Chatterjee S; Chakraborty C
    J Microsc; 2017 Nov; 268(2):172-185. PubMed ID: 28613390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. External validation of the ImmunoRatio image analysis application for ERα determination in breast cancer.
    Sundara Rajan S; Horgan K; Speirs V; Hanby AM
    J Clin Pathol; 2014 Jan; 67(1):72-5. PubMed ID: 23986557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokeratin-Supervised Deep Learning for Automatic Recognition of Epithelial Cells in Breast Cancers Stained for ER, PR, and Ki-67.
    Valkonen M; Isola J; Ylinen O; Muhonen V; Saxlin A; Tolonen T; Nykter M; Ruusuvuori P
    IEEE Trans Med Imaging; 2020 Feb; 39(2):534-542. PubMed ID: 31398111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninferiority of Artificial Intelligence-Assisted Analysis of Ki-67 and Estrogen/Progesterone Receptor in Breast Cancer Routine Diagnostics.
    Abele N; Tiemann K; Krech T; Wellmann A; Schaaf C; Länger F; Peters A; Donner A; Keil F; Daifalla K; Mackens M; Mamilos A; Minin E; Krümmelbein M; Krause L; Stark M; Zapf A; Päpper M; Hartmann A; Lang T
    Mod Pathol; 2023 Mar; 36(3):100033. PubMed ID: 36931740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the spatial dimension of estrogen and progesterone signaling: detection of nuclear labeling in lobular epithelial cells in normal mammary glands adjacent to breast cancer.
    Grote A; Abbas M; Linder N; Kreipe HH; Lundin J; Feuerhake F
    Diagn Pathol; 2014; 9 Suppl 1(Suppl 1):S11. PubMed ID: 25565114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of visual assessment and image analysis in the evaluation of Ki-67 expression and their prognostic significance in immunohistochemically defined luminal breast carcinoma.
    Arihiro K; Oda M; Ohara M; Kadoya T; Osaki A; Nishisaka T; Shiroma N; Kobayashi Y
    Jpn J Clin Oncol; 2016 Dec; 46(12):1081-1087. PubMed ID: 27511992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic potential of automated Ki67 evaluation in breast cancer: different hot spot definitions versus true global score.
    Robertson S; Acs B; Lippert M; Hartman J
    Breast Cancer Res Treat; 2020 Aug; 183(1):161-175. PubMed ID: 32572716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of immunohistochemistry with PCR for assessment of ER, PR, and Ki-67 and prediction of pathological complete response in breast cancer.
    Sinn HP; Schneeweiss A; Keller M; Schlombs K; Laible M; Seitz J; Lakis S; Veltrup E; Altevogt P; Eidt S; Wirtz RM; Marmé F
    BMC Cancer; 2017 Feb; 17(1):124. PubMed ID: 28193205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: results of an interlaboratory reproducibility ring study in China.
    Pu T; Shui R; Shi J; Liang Z; Yang W; Bu H; Li Q; Zhang Z;
    BMC Cancer; 2019 Oct; 19(1):978. PubMed ID: 31640622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation Index Evaluation in Breast Cancer Using ImageJ and ImmunoRatio Applications.
    Fulawka L; Halon A
    Anticancer Res; 2016 Aug; 36(8):3965-72. PubMed ID: 27466501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry.
    Tuominen VJ; Tolonen TT; Isola J
    Histopathology; 2012 Apr; 60(5):758-67. PubMed ID: 22296215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms.
    Ahern TP; Beck AH; Rosner BA; Glass B; Frieling G; Collins LC; Tamimi RM
    J Clin Pathol; 2017 May; 70(5):428-434. PubMed ID: 27729430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.